Stem Cell Therapy for Diabetes
Support metabolic balance and pancreatic health with regenerative MSC therapy.
Understanding Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by elevated blood glucose levels due to the body's inability to produce sufficient insulin (Type 1) or effectively use the insulin it produces (Type 2). Type 2 diabetes accounts for approximately 90% of all diabetes cases and is closely linked to lifestyle factors, obesity, and genetic predisposition.
Over time, persistently high blood sugar damages blood vessels and nerves, leading to serious complications including cardiovascular disease, kidney damage, vision loss, neuropathy, and impaired wound healing. Managing diabetes requires a comprehensive approach addressing blood sugar control, inflammation, and organ protection.
Regenerative medicine offers a complementary approach to diabetes management by targeting the underlying cellular dysfunction. MSC therapy aims to support pancreatic beta cell function, improve insulin sensitivity, and reduce the chronic inflammation that drives diabetic complications.
Common Symptoms
- Increased thirst and frequent urination
- Unexplained weight loss or gain
- Fatigue and weakness
- Blurred vision
- Slow-healing wounds and frequent infections
- Tingling or numbness in hands and feet
How MSC Therapy May Help
MSCs may support diabetes management through several mechanisms. They have demonstrated the ability to migrate to the pancreas and support the survival and function of insulin-producing beta cells. In Type 2 diabetes, MSCs may help improve insulin sensitivity by reducing chronic inflammation in metabolic tissues.
The immunomodulatory properties of MSCs are particularly relevant for Type 1 diabetes, where the immune system destroys beta cells. MSCs may help regulate this autoimmune response, potentially protecting remaining beta cells and creating conditions that support their regeneration.
Additionally, MSCs release anti-inflammatory and angiogenic factors that may help address diabetic complications such as neuropathy, vascular damage, and impaired wound healing. By improving blood vessel health and reducing oxidative stress, MSC therapy may support overall metabolic function and organ protection.
Our Treatment Approach
Metabolic Assessment
Comprehensive evaluation including HbA1c, fasting glucose, C-peptide levels, and metabolic panel to assess pancreatic function and overall metabolic health.
IV MSC Infusion
Systemic intravenous delivery of MSCs to address chronic inflammation, support pancreatic health, and improve metabolic function throughout the body.
Targeted Support
Additional treatments addressing specific diabetic complications such as neuropathy or vascular issues, with MSCs directed to areas of greatest need.
Lifestyle Integration
Nutritional counseling, exercise guidance, and ongoing monitoring to support sustained metabolic improvement and complement regenerative therapy.
Expected Benefits
- May support pancreatic beta cell function
- May help improve insulin sensitivity
- Supports reduction of chronic metabolic inflammation
- May help address diabetic complications
- Promotes vascular health and nerve function
- Supports overall metabolic balance
Frequently Asked Questions About Diabetes
MSC therapy is not a cure for diabetes but may serve as a supportive treatment that helps improve metabolic function. Research shows potential for improving insulin sensitivity, supporting beta cell survival, and reducing inflammation. The therapy is designed to complement your existing diabetes management plan.
MSC therapy may benefit both types. For Type 1, the immunomodulatory effects may help protect remaining beta cells. For Type 2, MSCs may improve insulin sensitivity and reduce metabolic inflammation. Your medical team will design a protocol specific to your diabetes type and stage.
MSC therapy does not replace insulin or other diabetes medications. Some patients have reported reduced medication needs over time, but any changes to your medication regimen should be made in close consultation with your endocrinologist based on measured improvements in metabolic markers.
We track multiple biomarkers including HbA1c, fasting glucose, C-peptide levels, and inflammatory markers before and after treatment. These objective measurements help assess the impact of therapy on pancreatic function and metabolic health over 3-6 months.
Ready to Explore Your Treatment Options?
Schedule a personalized consultation to discuss how MSC therapy may support your health journey.